ADC THERAPEUTICS SA -REDH ($ADCT) posted quarterly earnings results on Monday, November 10th. The company reported earnings of -$0.30 per share, beating estimates of -$0.37 by $0.07. The company also reported revenue of $16,430,000, missing estimates of $17,418,540 by $-988,540.
You can see Quiver Quantitative's $ADCT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ADC THERAPEUTICS SA -REDH Hedge Fund Activity
We have seen 34 institutional investors add shares of ADC THERAPEUTICS SA -REDH stock to their portfolio, and 44 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- POINT72 ASSET MANAGEMENT, L.P. added 7,763,658 shares (+inf%) to their portfolio in Q2 2025, for an estimated $20,806,603
- HEIGHTS CAPITAL MANAGEMENT, INC added 2,832,861 shares (+inf%) to their portfolio in Q2 2025, for an estimated $7,592,067
- NANTAHALA CAPITAL MANAGEMENT, LLC added 2,266,289 shares (+inf%) to their portfolio in Q2 2025, for an estimated $6,073,654
- PROSIGHT MANAGEMENT, LP added 924,767 shares (+9.7%) to their portfolio in Q2 2025, for an estimated $2,478,375
- PLATINUM INVESTMENT MANAGEMENT LTD removed 650,822 shares (-31.9%) from their portfolio in Q2 2025, for an estimated $1,744,202
- BANK OF AMERICA CORP /DE/ added 397,905 shares (+22.1%) to their portfolio in Q2 2025, for an estimated $1,066,385
- BLACKROCK, INC. removed 392,285 shares (-8.0%) from their portfolio in Q2 2025, for an estimated $1,051,323
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ADC THERAPEUTICS SA -REDH Analyst Ratings
Wall Street analysts have issued reports on $ADCT in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 06/20/2025
- Guggenheim issued a "Buy" rating on 06/13/2025
To track analyst ratings and price targets for ADC THERAPEUTICS SA -REDH, check out Quiver Quantitative's $ADCT forecast page.
ADC THERAPEUTICS SA -REDH Price Targets
Multiple analysts have issued price targets for $ADCT recently. We have seen 4 analysts offer price targets for $ADCT in the last 6 months, with a median target of $7.5.
Here are some recent targets:
- Robert Burns from HC Wainwright & Co. set a target price of $7.0 on 10/16/2025
- Michael Schmidt from Guggenheim set a target price of $10.0 on 08/13/2025
- Leonid Timashev from RBC Capital set a target price of $5.0 on 06/20/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
